UVA Health Prince William Medical Center is now offering Aquablation therapy, “an advanced, AI-powered minimally invasive treatment for benign prostatic hyperplasia (BPH), or enlarged prostate.”
BPH affects “about half of men over their lifetime, yet fewer than 3% of those diagnosed receive procedural treatment. As the prostate enlarges, it can restrict the urethra and strain the bladder, leading to frequent urination, a weak stream, and sleep disruption.”
Aquablation uses a “high-pressure, heat-free water jet guided by real-time imaging, robotics, and artificial intelligence to remove excess prostate tissue while preserving surrounding structures.” Benefits can include shorter procedure times, “reduced reliance on long-term medication, faster recovery, and lower rates of irreversible complications.” It also allows for more personalization in each patient’s treatment.
BPH is highly common, but treatable. Patients may experience “relatively minor symptoms early on, [but] many do not seek treatment until symptoms become severe.”
